4th Quarter - Report
ELEKTA, INC. for ELEKTA, INC.
Firm
Client
Income
—
Expenses
$39,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Energy/Nuclear ENG
Cobalt-60 issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| COOKAB HASHEMI | Senior Director, Government Affairs, Policy & Reimbursement |
Health Issues HCR
Oncology issues ROCR, S.4330/H.R.8404
| Lobbyist | Covered position, as disclosed |
|---|---|
| COOKAB HASHEMI | Senior Director, Government Affairs & Policy |
Medicare/Medicaid MMM
Medicare Part B ROCR, S.4330/H.R. 8404
| Lobbyist | Covered position, as disclosed |
|---|---|
| COOKAB HASHEMI | Senior Director, Government Affairs & Policy |
Medical/Disease Research/Clinical Labs MED
Medical Research & Development
| Lobbyist | Covered position, as disclosed |
|---|---|
| COOKAB HASHEMI | Senior Director, Government Affairs & Policy |
Science/Technology SCI
Science issues Technology issues related to Medical Devices
| Lobbyist | Covered position, as disclosed |
|---|---|
| COOKAB HASHEMI | Senior Director, Government Affairs & Policy |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ELEKTA | Sweden | Sweden | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.